Bio-Rad Laboratories, Inc. (BIO) is set to release fourth-quarter 2023 results on Feb 15 after the closing bell. The company posted adjusted earnings per share (EPS) of $2.33 in the last reported quarter, missing the Zacks Consensus Estimate by 18.8%. Bio-Rad beat earnings estimates in three of the trailing four quarters and missed the same in one, the average negative surprise being 0.54%. Let’s look at how things have shaped up before this announcement. Factors at Play Life Science The Life Science segmen ...